CY1110116T1 - Νευροεκφυλιστικοι δεικτες για καταθλιψη - Google Patents

Νευροεκφυλιστικοι δεικτες για καταθλιψη

Info

Publication number
CY1110116T1
CY1110116T1 CY20101100535T CY101100535T CY1110116T1 CY 1110116 T1 CY1110116 T1 CY 1110116T1 CY 20101100535 T CY20101100535 T CY 20101100535T CY 101100535 T CY101100535 T CY 101100535T CY 1110116 T1 CY1110116 T1 CY 1110116T1
Authority
CY
Cyprus
Prior art keywords
neuroendocrine
indicators
depression
disease
values
Prior art date
Application number
CY20101100535T
Other languages
English (en)
Inventor
Aye Mu Myint
Manfred Schawaller
Robert Verkerk
Markus J Schwarz
NORBERT MüLLER
Original Assignee
Verstappen, Leopold
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Verstappen, Leopold filed Critical Verstappen, Leopold
Publication of CY1110116T1 publication Critical patent/CY1110116T1/el

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9406—Neurotransmitters
    • G01N33/942—Serotonin, i.e. 5-hydroxy-tryptamine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555—Hetero-N

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Eye Examination Apparatus (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Mushroom Cultivation (AREA)
  • Input From Keyboards Or The Like (AREA)

Abstract

Η παρούσα εφεύρεση αφορά μεθόδους ανίχνευσης μιας ψυχιατρικής κατάστασης προαιρετικώς συνδυασμένη με μια κατάθλιψη, που περιλαμβάνει τα στάδια μέτρησης της συγκέντρωσης τουλάχιστον ενός in vivo προϊόντος αποικοδόμησης της τρυπτοφάνης. Περαιτέρω, η παρούσα εφεύρεση αφορά τη χρήση των εν λόγω τιμών ως δεικτών πρόβλεψης για την ανίχνευση μιας ψυχιατρικής κατάστασης που προαιρετικά συνδυάζεται με κατάθλιψη και ένα κιτ που περιέχει μέσα για ανίχνευση των εν λόγω τιμών.
CY20101100535T 2005-04-06 2010-06-11 Νευροεκφυλιστικοι δεικτες για καταθλιψη CY1110116T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05007558 2005-04-06
EP06723873A EP1866650B1 (en) 2005-04-06 2006-03-30 Neurodegenerative markers for depression.

Publications (1)

Publication Number Publication Date
CY1110116T1 true CY1110116T1 (el) 2015-01-14

Family

ID=36293430

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101100535T CY1110116T1 (el) 2005-04-06 2010-06-11 Νευροεκφυλιστικοι δεικτες για καταθλιψη

Country Status (14)

Country Link
US (2) US20080131921A1 (el)
EP (2) EP1866650B1 (el)
JP (1) JP4958893B2 (el)
AT (2) ATE534038T1 (el)
CY (1) CY1110116T1 (el)
DE (1) DE602006014379D1 (el)
DK (2) DK1866650T3 (el)
ES (2) ES2346467T3 (el)
HK (1) HK1137219A1 (el)
NO (2) NO20075671L (el)
PL (2) PL2146209T3 (el)
PT (2) PT2146209E (el)
SI (1) SI1866650T1 (el)
WO (1) WO2006105907A1 (el)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2053405A4 (en) * 2006-08-04 2009-11-11 Ajinomoto Kk METHOD FOR EVALUATING STRESS, STRESS EVALUATION DEVICE, STRESS EVALUATION METHOD, STRESS EVALUATION SYSTEM, STRESS EVALUATION PROGRAM AND RECORDING MEDIUM
AT9843U1 (de) 2007-03-27 2008-04-15 Kepplinger Berthold Dr Messung von biologischen markern
NZ602007A (en) 2008-01-18 2014-09-26 Harvard College Methods of detecting signatures of disease or conditions in bodily fluids
WO2009096502A1 (ja) * 2008-01-31 2009-08-06 Japan As Represented By President Of National Center Of Neurology And Psychiatry うつ病およびうつ状態のマーカーおよびそれを用いた検出・診断
WO2009100243A2 (en) * 2008-02-05 2009-08-13 University Of Miami Elavl4 as a predictor of depression in alzheimer's disease and parkinson's disease patients
JPWO2011019072A1 (ja) 2009-08-12 2013-01-17 ヒューマン・メタボローム・テクノロジーズ株式会社 うつ病のバイオマーカー、うつ病のバイオマーカーの測定法、コンピュータプログラム、及び記憶媒体
WO2012012717A1 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting prenatal or pregnancy-related diseases or conditions
SG10201505724SA (en) 2010-07-23 2015-09-29 Harvard College Methods of detecting diseases or conditions using phagocytic cells
EP4303584A3 (en) 2010-07-23 2024-04-03 President and Fellows of Harvard College Methods for detecting signatures of disease or conditions in bodily fluids
WO2012012694A2 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
CN106399458A (zh) 2011-11-10 2017-02-15 福满代谢组技术有限公司 乙醇胺磷酸酯的测定方法
MX2014015434A (es) 2012-06-15 2015-07-14 Harry Stylli Metodos para detectar enfermedades o condiciones utilizando celulas enfermas en circulacion.
KR20150035821A (ko) 2012-06-15 2015-04-07 해리 스타일리 질환 또는 병태를 검출하는 방법
US20150285805A1 (en) 2012-11-05 2015-10-08 Ospedale San Raffaele S.R.L. Biomarkers of multiple myeloma development and progression
US10494675B2 (en) 2013-03-09 2019-12-03 Cell Mdx, Llc Methods of detecting cancer
EP3385717A3 (en) 2013-03-09 2018-10-24 Harry Stylli Methods of detecting prostate cancer
EP2799878A1 (en) * 2013-05-03 2014-11-05 SALION GmbH In vitro method for the early detection of a potential inflammation, in particular associated with rejection of a transplant using kynurenine as a marker.
US20160003857A1 (en) * 2014-07-02 2016-01-07 Cecil Bennett Methods and systems for detecting polypharmacy
MA40636A (fr) 2014-09-11 2015-09-11 Colleen Kelly Procédés pour détecter le cancer de la prostate
US11806385B2 (en) 2016-04-22 2023-11-07 Board Of Regents Of The University Of Nebraska Biomarkers for monitoring immune transformation
EP3413050A1 (en) * 2017-06-08 2018-12-12 SALION GmbH In vitro method for the determination of neurodegenerative diseases
CA3077211A1 (en) * 2017-09-27 2019-04-04 University of North Carolina Wilmington Human waste water and human-derived pathogen scouting tool
KR20200134205A (ko) 2018-03-19 2020-12-01 후지필름 와코 준야쿠 가부시키가이샤 정신 질환의 판정 방법
WO2019182003A1 (ja) * 2018-03-22 2019-09-26 株式会社日本医療機器技研 生体吸収性ステント
KR102159344B1 (ko) * 2019-08-05 2020-09-23 한국과학기술연구원 행위 중독의 진단용 조성물, 키트 및 이를 이용한 행위 중독의 진단을 위한 키누레닌의 검출 방법
EP4067903A4 (en) * 2019-11-26 2024-03-06 Kyocera Corporation LOAD MEASUREMENT SYSTEM AND LOAD MEASUREMENT METHOD
JP2023549028A (ja) * 2020-10-06 2023-11-22 学校法人沖縄科学技術大学院大学学園 アルツハイマー病（ａｄ）の診断のための指標を得るための方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6194217B1 (en) * 1980-01-14 2001-02-27 Esa, Inc. Method of diagnosing or categorizing disorders from biochemical profiles
JP2000131318A (ja) * 1998-10-22 2000-05-12 Nikken Foods Co Ltd 快・不快ストレス状態解析方法
EP1050758A1 (en) * 1999-05-03 2000-11-08 Evotec BioSystems AG Methods of diagnosing or treating neuropsychiatric diseases on basis of increased cerebrospinal fluid levels of neurotrophin 3
FR2827045B1 (fr) * 2001-07-05 2007-08-10 Univ Pasteur Methodes et compositions pour la selection et le developpement de nouveaux agents pharmacologiques ou de nouveaux medicaments
JP2004198325A (ja) * 2002-12-19 2004-07-15 Oriental Yeast Co Ltd ストレスの測定方法

Also Published As

Publication number Publication date
EP1866650B1 (en) 2010-05-19
HK1137219A1 (en) 2010-07-23
JP2008537111A (ja) 2008-09-11
NO20075671L (no) 2007-11-06
SI1866650T1 (sl) 2010-12-31
US20120196300A1 (en) 2012-08-02
DK2146209T3 (da) 2012-02-13
EP2146209A1 (en) 2010-01-20
JP4958893B2 (ja) 2012-06-20
PT2146209E (pt) 2011-12-30
DE602006014379D1 (de) 2010-07-01
WO2006105907A1 (en) 2006-10-12
DK1866650T3 (da) 2010-09-06
PL2146209T3 (pl) 2012-05-31
EP2146209B1 (en) 2011-11-16
EP1866650A1 (en) 2007-12-19
ATE468537T1 (de) 2010-06-15
ATE534038T1 (de) 2011-12-15
ES2377704T3 (es) 2012-03-30
ES2346467T3 (es) 2010-10-15
PT1866650E (pt) 2010-06-01
NO20120452L (no) 2007-11-06
US20080131921A1 (en) 2008-06-05
PL1866650T3 (pl) 2011-04-29

Similar Documents

Publication Publication Date Title
CY1110116T1 (el) Νευροεκφυλιστικοι δεικτες για καταθλιψη
WO2006134390A3 (en) Method for diagnosing neurodegenerative disease
MX2007016136A (es) Metodo para diagnosticar la enfermedad de alzheimer.
WO2005045393A3 (en) Determination of a measure of a glycation end-product or disease state using tissue fluorescence
WO2008089994A8 (en) Use of igfbp-7 in the assessment of heart failure
WO2008148072A3 (en) Disease-associated genetic variations and methods for obtaining and using same
IL163636A0 (en) Device, system and method for temperature sensing in an in-vivo device
WO2006090389A3 (en) Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof
WO2007030949A3 (en) Methods of diagnosing ovarian cancer and kits therefor
WO2007106762A3 (en) Alzheimer's disease biomarkers and methods of use
PL2021794T3 (pl) Zastosowanie białka S100A 12 jako markera raka okrężnicy i odbytnicy
ATE551357T1 (de) Markerpeptid für die alzheimer-krankheit
DE602004006664D1 (de) Vorrichtung zum Feststellen der Verschlechterung eines Sauerstoffkonzentrationsensors
FR2874675B1 (fr) Frein pour roue avec capteur d'usure
DE602007006671D1 (de) Verwendung von nnmt als marker für lungenkrebs
WO2006066917A3 (en) Use of asc as a marker for colorectal cancer
WO2007060647A3 (en) A method for detecting or monitoring sepsis by analysing cytokine mrna expression levels
WO2010000467A8 (en) Asc as a marker for lung cancer
DE602007004570D1 (de) Verwendung von Nogo-C bei der Beurteilung von Herzversagen
WO2010043393A8 (en) Use of biglycan in the assessment of heart failure
ATE414904T1 (de) Verfahren zum testen des oxidiertes-ldl-beta-2- glycoprotein-i-komplexes in vivo
ATE442084T1 (de) Messung des energieverbrauchs
ATE530548T1 (de) Neue dibenzoäc,hüä1,5ü naphthyridine und ihre verwendung als dna-sonden
BRPI0417802A (pt) adaptador de capnÈmetro nanoelétrico
FR2852096B1 (fr) Instrument indicateur de direction permettant d'indiquer l'heure et la direction de la mecque.